JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div.…
- Recall date
- September 12, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0033-2026
- FDA classification
- Class III
- Brand / firm
- JB Chemicals and Pharmaceuticals Ltd
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Tablet/Capsules Imprinted with Wrong ID
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50
Get recall alerts
Free email alert whenever JB Chemicals and Pharmaceuticals Ltd has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: JB Chemicals and Pharmaceuticals Ltd